News articles

grafica_4

EU Grants a Project to Test an Innovative HIV Vaccine Candidate in two phase I/IIa clinical trials

EU Grants a Project to Test an Innovative HIV Vaccine Candidate in two phase I/IIa clinical trials

 The iHIVARNA strategy proposes using an mRNA-based therapeutic vaccine encoding HIV antigens as a novel and promising approach in HIV immunotherapy. The four-year 6M€ European project iHIVARNA, funded by the European Commission, aims to successfully immunize antiretroviral-treated HIV-infected patients with 3 injections of the candidate universal HIV-TriMix-mRNA as an mRNA-based therapeutic vaccine with the final

Top